|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-08
|
$284,744
|
$71,186
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
5K23CA157728-05
|
$173,598
|
$86,799
|
ANDERS, CAREY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Breast Cancer
|
5P50CA098131-13
|
$2,185,000
|
$546,250
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
5R01CA154738-05
|
$562,844
|
$281,422
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$1,250
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$2,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$1,586
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$72,930
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
$54,099
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$113,744
|
$11,374
|
Bates, Susan
|
CCR (NCI)
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
1U01CA185148-01A1
|
$324,705
|
$107,153
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-33S1
|
$62,500
|
$1,875
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
$75,874
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$20,084
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$719,019
|
$107,853
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
5R21CA182692-02
|
$168,563
|
$84,282
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Mitigating Taxol-Induced Neuropathy through Modulation of the NMDA Receptor
|
1R43CA199928-01
|
$197,633
|
$197,633
|
BURGDORF, JEFF
|
NAUREX, INC.
|
|
Cancer Center Support Grant
|
3P30CA016058-39S1
|
$62,500
|
$625
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S2
|
$60,126
|
$601
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S3
|
$31,250
|
$313
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-39
|
$4,582,303
|
$45,823
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Hsp60 regulation of apoptosis in prostate cancer
|
5R01CA160685-03
|
$252,894
|
$75,868
|
CHANDRA, DHYAN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Juxtacrine regulation of metastasis from brain microenvironments
|
1K22CA181470-01
|
$195,990
|
$48,998
|
CHEN, QING
|
WISTAR INSTITUTE
|
|
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
|
5R01CA175480-03
|
$327,765
|
$163,883
|
CHENG, ZHILIANG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer
|
5R01CA158881-05
|
$523,530
|
$261,765
|
COLEMAN, TIMOTHY
|
NEMUCORE MEDICAL INNOVATIONS, INC.
|
|
Regulating the Immune Microenvironment in Breast Cancer
|
5R01CA155331-06
|
$319,550
|
$105,452
|
COUSSENS, LISA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-29S1
|
$89,185
|
$6,243
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
$103,950
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Camptothecin Transformative Nanotubes as Effective Drug Carriers
|
1R21CA191740-01A1
|
$206,333
|
$103,167
|
CUI, HONGGANG
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$7,911
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$2,499
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$1,367
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$4,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$30,700
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$530,118
|
$26,506
|
Dahut, William
|
CCR (NCI)
|
|
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
|
1R01CA182435-01A1
|
$344,269
|
$344,269
|
DATTA, KAUSTUBH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Cancer Center Support Grant
|
2P30CA047904-27
|
$5,129,654
|
$153,890
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-27S2
|
$115,192
|
$3,456
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-27S3
|
$60,000
|
$1,800
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-13S1
|
$97,870
|
$2,936
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-13S2
|
$59,969
|
$1,799
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-13S3
|
$124,934
|
$3,748
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
5P30CA093373-13
|
$3,138,579
|
$94,157
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-41
|
$5,755,389
|
$57,554
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
3P30CA072720-18S2
|
|
$0
|
DIPAOLA, ROBERT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Cancer Center Support Grant
|
3P30CA072720-18S3
|
$43,750
|
$438
|
DIPAOLA, ROBERT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Cancer Center Support Grant
|
3P30CA072720-18S4
|
$124,999
|
$1,250
|
DIPAOLA, ROBERT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Cancer Center Support Grant
|
5P30CA072720-18
|
$2,922,756
|
$29,228
|
DIPAOLA, ROBERT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S1
|
$60,000
|
$600
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
Total relevant funding to Taxol for this search: $15,468,676
|